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ABSTRACT 
The purpose of this study was to examine the effects 
of tracheostomy cuff deflation and Passy-Muir 
Tracheostomy Speaking Valve placement on the incidence 
and severity of aspiration. In addition, the effects of 
cuff deflation and Passy-Muir valve placement on 
durational swallow measures were examined. 
Fourteen non-ventilator dependent patients completed 
videofluoroscopic swallow studies (VFSS) under three 
conditions: 1) cuff inflated, 2) cuff deflated, and 3) 
Passy-Muir valve in place. Four additional patients with 
cuffless tracheostomy tubes completed VFSS with no cuff 
and with the Passy-Muir valve in place. The order in 
which each participant completed these conditions was 
randomized. Participants were given two 5-mL boluses of 
thin liquid and two 5-mL boluses of puree. All VFSS were 
analyzed by a judge who was blinded to the condition 
under which each swallow was completed. All swallows 
were analyzed for the presence or absence of penetration 
or aspiration, the timing of aspiration, if present, and 
the severity of penetration/aspiration based on an a-
point penetration-aspiration scale (Rosenbek, Robbins, 
Roecker, Coyle, & Wood, 1996). In addition, swallows 
were analyzed for the following duration measures: oral 
transit duration (OTD), stage transition duration (STD), 
pharyngeal transit duration (PTD), duration of hyoid 
maximum elevation (DOHME), duration of hyoid maximum 
anterior excursion (DOHMAE), duration of cricopharyngeal 
opening (DOCPO), and total swallow duration (TSD). 
Maximum hyolaryngeal elevation and anterior excursion 
were also determined. 
Scores on the penetration-aspiration scale were not 
significantly affected by cuff deflation. The Passy-Muir 
valve did, however, significantly reduce scores on the 
penetration-aspiration scale for the liquid bolus. For 
those patients who had cuffed tracheostomy tubes, there 
was a significant difference in penetration-aspiration 
scale scores between the cuff-inflated and the Passy-Muir 
valve conditions. 
The major positive finding in this investigation was 
that placement of the Passy-Muir valve reduced 
penetration/aspiration on an 8-point scale. In order to 
swallow more safely, patients who are able to tolerate 
Passy-Muir valve placement may benefit from eating with 
the valve in place. 
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Pulmonary aspiration, which may be defined as, "the 
penetration of secretions or ingesta below the level of the 
true vocal folds" (Perlman & Schulze-Delrieu, 1997, p. 
492), frequently occurs as a result of oropharyngeal 
dysphagia. Aspiration is known to occur in normal, healthy 
individuals without detrimental effects (Crausaz & Favez, 
1988; Huxley, 1978). In fact, Finegold (1995) has 
estimated that 50% of normal subjects aspirate during 
sleep. However, in patients with compromised medical 
status, aspiration can lead to serious consequences 
including bronchospasm, chemical pneumonitis, bacterial 
pneumonia, mechanical obstruction of the airways, or 
transient hypoxemia (Kirsch & Sanders, 1988; Passy-Muir, 
1996) . 
Aspiration pneumonia has received considerable 
attention from individuals working with swallowing problems 
because it frequently occurs subsequent to the development 
of dysphagia and hospitalization (Langmore et al., 1998) 
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and reportedly accounts for between 13% and 48% of all 
infections in nursing homes (Crossley & Thurn, 1989; 
Zimmer, Bentley, Valenti, Watson, 1986). In addition, 
aspiration pneumonia is the second most common type of 
nosocomial infection in hospitalized patients (Horan, et 
al., 1986). Langmore and colleagues (1998) report ~overall 
mortality rate ranges from 20% to 50%, with a rate as high 
as 80% reported in some cases" (p. 69). Wenzel (1989) 
estimated that the extra hospitalization time directly 
attributable to pneumonia is 2.5 million days annually in 
the United States. 
Incidence of Aspiration 
The incidence of aspiration has been reported in 
various patient populations. Veis and Logemann (1985) 
evaluated 38 stroke patients through videofluoroscopic 
swallowing studies. Of the 38 patients studied, 32% 
aspirated secondary to pharyngeal phase dysphagia. 
Logemann and Bytell (1979) reported a 50% incidence of 
aspiration in head and neck surgical patients. Lazarus and 
Logemann (1987) observed aspiration in 20 of 53 (37%) 
patients with head injuries. Studies have estimated the 
incidence of aspiration in patients with tracheostomy tubes 
to be as high as 87% (Pannuzio, 1996). 
TRACHEOTOMY 
Tracheotomy is one of the most commonly performed 
surgical procedures in acute care hospitals, frequently 
used to treat patients with chronic or acute upper airway 
obstruction or chronic respiratory failure. It is also 
employed by many physicians to aid in the care of patients 
with chronic aspiration. However, Nash (1988) reports, 
"the major swallowing disorder associated with tracheotomy 
is aspiration" (p. 705). In addition, Nash states that 
while "many physicians conceive of a tracheotomy as a 
solution to long-term aspiration ... in reality a tracheotomy 
may increase the problem rather than solve it" (p. 705). 
TREATMENT FOR ASPIRATION IN TRACHEOSTOMZED PATIENTS 
Cuff Deflation 
With the high incidence of aspiration in 
tracheostomized patients and the potential development of 
aspiration pneumonia, it is essential to carefully evaluate 
and treat tracheostomized patients for aspiration. Some 
methods have been proposed for treating aspiration in 
tracheostomy patients. It has been postulated that simply 
deflating the tracheostomy cuff may decrease the risk of 
aspiration. Tippett and Siebens (1991) found that to be 
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the case. Suiter, McCullough, and Powell (in preparation) 
found opposite results. They examined 12 non-ventilator 
dependent patients and found that cuff deflation had no 
significant effect on the incidence or severity of 
aspiration. 
Passy-Muir Tracheostomy Speaking Valve Placement 
Other researchers have suggested that placing a Passy-
Muir Tracheostomy Speaking Valve eliminates or 
significantly reduces aspiration. Dettelbach, Gross, 
Mahlmann, and Eibling (1995) studied the effects of the 
Passy-Muir Tracheostomy Speaking Valve on swallowing in 11 
patients with tracheostomy tubes. The authors reported 
that in all patients aspiration was significantly reduced 
when the Passy-Muir valve was in place. However, the 
authors did not control for certain factors, such as 
population, and confounded some of their results by 
introducing compensatory swallowing strategies. In 
addition, the authors did not state how they determined 
amount of aspiration, nor did they report reliability for 
judgments of degree of aspiration. Thus, the reliability 
of these findings is highly questionable. 
Leder (1999) found opposite results. He used 
fiberoptic endoscopy to examine the effects of a one-way 
4 
valve on swallowing function in 20 consecutive 
tracheostomized inpatients with various diagnoses. Results 
indicated that 13 subjects who aspirated without the one-
way valve in place also aspirated with the one-way valve. 
Conversely, seven subjects who did not aspirate without the 
valve also did not aspirate with the valve in place. Leder 
concluded that the incidence of aspiration was not affected 
by use of a one-way speaking valve. However, the author 
did not seek to quantify the severity of aspiration. 
Rather, aspiration was reported to be either present or 
absent. Thus, it is unclear if the valve truly had no 
effect on swallowing. 
PURPOSE OF THE STUDY 
The purpose of this paper is to determine whether 
Passy-Muir valve placement can decrease the incidence and 
severity of aspiration in tracheostomized individuals. 
In addition, the effects of cuff deflation on incidence and 
severity of aspiration were examined. 
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CHAPTER TWO 
REVIEW OF THE LITERATURE 
INCIDENCE OF ASPIRATION IN TRACHEOSTOMIZED PATIENTS 
Several researchers have reported the incidence of 
aspiration resulting from tracheostomy. Devita and 
Spierer-Rundback (1990) examined swallowing function in 11 
patients following prolonged orotracheal intubation. Ten 
patients had tracheostomy tubes in place at the time of 
evaluation. Videofluoroscopic swallow studies (VFSS) 
revealed oral phase dysphagia in four patients and 
pharyngeal phase dysphagia in all ten patients. Tracheal 
penetration was noted in five patients. 
Bone, Davis, Zuidema, and Cameron (1974) employed the 
modified Evans blue dye test to assess swallow function in 
40 tracheostomized patients. Patients had one of three 
types of tracheostomy tubes in place at the time of the 
study: 1) standard tracheostomy tube; 2) high-volume, low-
pressure cuff; and 3) sponge-filled cuff. Eighty-seven 
percent of participants with standard tracheostomy tubes 
aspirated; 15% of participants with high-volume, low-
pressure cuffs aspirated; and 17% of participants with 
sponge-filled cuffs aspirated. The sensitivity of the blue 
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dye test has been questioned (Brady, Hildner, & Hutchins, 
1999). 
Elpern, Jacobs, and Bone (1987) also employed the 
modified Evans blue dye test to assess swallowing in 
tracheostomized patients. Thirty-one participants were 
examined. Swallowing was evaluated over a series of six to 
61 observations. The mean number of observations per 
patient was 28. Seventy-seven percent of participants 
aspirated during at least one of the observations. 
Aspiration was most frequently noted when the participants' 
tracheostomy cuffs were inflated. 
Elpern, Scott, Petro, and Ries (1994) sought to 
determine the incidence of aspiration in 83 ventilator-
dependent patients. All participants underwent 
videofluoroscopic-swallowing studies. Half of the 
participants aspirated on at least one occasion. Seventy-
seven percent of aspiration occurrences were silent. 
Pharyngeal phase dysfunction was observed twice as 
frequently as oral phase dysfunction. 
The effect of tracheostomy tubes on swallowing has 
been questioned by Leder and Ross (2000). These scientists 
used fiberoptic endoscopy to evaluate swallowing in 20 
patients pre- and post-tracheotomy. Time from pre-
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operative endoscopy to post-operative endoscopy ranged from 
two days to 63 days. Nineteen of the 20 patients exhibited 
the same aspiration status post-tracheotomy as they did 
pre-tracheotomy. In other words, nineteen of the patients 
who aspirated before tracheotomy also aspirated after 
tracheotomy. The results of this study are questionable, 
however, because of the variation and length of time 
between pre- and post-operative testing. Patients with 
tracheostomy tubes are frequently medically fragile, and 
their medical status often changes quickly. Changes in 
medical status may have affected the outcome of their 
swallowing examination. 
TRACHEOSTOMY EFFECTS ON SWALLOWING 
Decreased Hyolaryngeal Excursion 
Several theories regarding the effects of tracheostomy 
on swallowing have been postulated. Several authors 
(Bonanno, 1971; Elpern et al., 1994; Logemann, 1995; 
Pinkus, 1973) have observed markedly decreased elevation 
and anterior rotation of the larynx in a population of 
patients with tracheostomy tubes, presumably as a result of 
the tracheostomy tube anchoring the trachea to the strap 
muscles and skin of the neck. This, in turn, leads to 
insufficient relaxation of the cricopharyngeal sphincter, 
with resultant residue in the pharynx, which eventually 
spills into the airway and is aspirated. Laryngeal 
elevation may also be restricted by an inflated tracheal 
cuff anchoring the larynx or by the weight of ventilator 
tubing. 
Tracheostomy Cuff Problems 
Others (Betts, 1965) have postulated that the 
tracheostomy cuff may impinge on the wall of the esophagus, 
creating an esophageal obstruction that forces material to 
remain above the cuff in the proximal esophagus and 
hypopharynx. When the cuff is deflated, or the patient 
exhales forcefully, this material may then overflow into 
the airway. Tippett and Siebens (1991) report that "a 
tracheostomy cannula with an inflated cuff adversely 
affects upper airway clearance and laryngeal protection 
against entry of foodway contents" (p. 97). These authors 
also state that tracheostomy cuffs provide imperfect 
protection against aspiration, and "seepage of foodway 
products is likely" (p. 97). 
Decreased Adductor and Abductor Vocal Fold Movement 
Yet another theory suggests that tracheostomy has a 
detrimental effect on adductor and abductor vocal fold 
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movement. Buckwalter and Sasaki (1984) demonstrated that 
the threshold of the adductor reflex produced by superior 
laryngeal nerve electrostimulation nearly doubles after a 
tracheostomy has been in place for a prolonged period of 
time (six to eight months). They also found that 
repetitive stimulation of the superior laryngeal nerve 
results in significant attenuation of the adductor reflex, 
which leads to a weakened closure response and, possibly, 
to aspiration. In addition, abductor vocal fold activity 
gradually diminishes and eventually disappears with 
prolonged tracheostomy. 
Laryngeal Abnormalities 
Tolep, Getch, and Criner (1996) performed direct 
laryngoscopy on ten patients with tracheostomy tubes. In 
five of ten of these patients the authors found laryngeal 
abnormalities, including decreased sensation of the vocal 
folds, limited vocal fold movement, and edema of the 
arytenoid cartilages. These abnormalities may limit upper 
airway protection. 
Reduced Subglottal Pressure 
Finally, tracheostomy tubes have a negative effect on 
subglottal pressure (Gross, Dettelbach, Zajac, Eibling, 
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1994; Sasaki & Isaacson, 1988). Under normal conditions, 
the trachea acts as a wind tunnel, and increased subglottal 
pressure relative to supraglottal pressure keeps food and 
liquid out of the airway. When the trachea is opened (by a 
tracheostomy tube), subglottal pressure drops, and material 
can more readily enter the airway. 
APPROACHES TO REDUCING ASPIRATION 
Non-Oral Means of Nutrition 
Several different approaches have been taken to reduce 
aspiration in patients with tracheostomy tubes. The first 
and perhaps most frequently employed approach is to place a 
patient on a non-oral means of nutrition and provide 
enteral feeding via a nasogastric or PEG tube. However, 
the presence of a nasogastric tube itself may increase a 
patient's risk of aspiration. Arms, Dines, and Tinstman 
(1974) studied a group of patients who had been diagnosed 
with aspiration pneumonia to determine risk factors for 
aspiration. These authors concluded that, ~the most 
important high risk factors in patients of the group with 
operation [versus no operation] included the presence of a 
nasogastric tube or tracheostomy at the time of aspiration" 
(p. 138). In this study, 54% of the aspiration occurred 
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around a nasogastric tube. Gilbert, Bryce, Mcilwain, and 
Ross (1987) theorized that the presence of a nasogastric 
tube might interfere with relaxation of the cricopharyngeal 
sphincter and thus lead to residue in the hypopharynx or 
backflow of material into the pharynx. Material may then 
be aspirated after the swallow. In addition, nasogastric 
tubes may interfere with the normal function of the lower 
esophageal sphincter and allow for gastroesophageal reflux. 
Kirsch and Sanders (1988) reported that the "proper 
placement of a nasoenteral tube for the purpose of 
alimentation is associated with a 38 percent incidence of 
aspiration in patients who have either endotracheal or 
tracheostomy tubesu (p. 681). 
Laryngotracheal Diversion and Separation 
Two other approaches to treating aspiration in the 
tracheostomized patient are laryngotracheal diversion and 
separation. These procedures were designed to treat 
patients with moderate to severe aspiration. 
Specifically, laryngotracheal diversion, as described by 
Lindeman, consists of "tracheal division with construction 
of an end-to-side tracheoesophageal anastamosis and a 
distal tracheostomyn (Snyderman, Johnson, Eibling, 1994, p. 
64). Reportedly, Lindeman was able to preserve laryngeal 
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function using this procedure with dogs (Snyderman et al.). 
Laryngotracheal separation, or the modified "Lindeman 
procedure," consists of "oversewing the proximal trachea to 
create a blind pouch" (Snyderman et al., p. 64). This 
procedure is typically used for patients with pre-existing 
tracheostomies that "preclude the establishment of a 
tracheoesophageal anastamosis" (Snyderman et al., p. 64). 
According to Snyderman and associates, aspiration was 
effectively eliminated in over 100 reported cases of 
laryngotracheal separation. This procedure, however, has 
obvious drawbacks, including the obliteration of laryngeal 
function and the loss of the patient's ability to phonate. 
Cuff Deflation 
Less invasive methods have been investigated. Tippett 
and Siebens (1991) suggest that deflation of a tracheostomy 
cuff could eliminate aspiration. Specifically, the authors 
studied the effects of cuff deflation on swallowing in five 
tracheostomized patients. Of the three patients who were 
receiving non-oral means of nutrition prior to the study, 
all were able to safely take oral alimentation with their 
tracheostomy cuffs deflated. Suiter, McCullough, and 
Powell (in preparation) found opposite results. They 
examined 12 non-ventilator dependent patients under two 
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conditions, cuff-inflated and cuff-deflated, using 
videofluoroscopy. Their results indicated no significant 
effect of cuff deflation on durational measures of 
swallowing or the incidence and severity of aspiration. 
Tracheostomy Tube Occlusion 
Several authors have suggested that placement of an 
obturator on the tracheostomy tube may reduce or eliminate 
aspiration by restoring subglottal pressure. Muz, Hamlet, 
Mathog, and Farris (1994) studied a group of head and neck 
cancer patients using scintigraphy. In seven patients who 
aspirated, they examined the effects of occluding the 
tracheostomy tube while patients swallowed. Their results 
indicated that in six of the seven patients, 
tracheopulmonary aspiration was less frequent and less 
severe when the tracheostomy tube was plugged than when it 
was unplugged. The authors went so far as to suggest that, 
for those patients who could tolerate it, the tracheostomy 
tube should be intermittently occluded during eating. 
However, many patients, particularly those who are 
ventilator-dependent, are unable to tolerate total 
occlusion of their tracheostomy tubes for any period of 
time. 
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Logemann, Pauloski, and Colangelo (1998) examined the 
effects of digital occlusion of the tracheostomy valve in 
eight head and neck cancer patients and found mixed 
results. Four out of seven patients exhibited aspiration 
of thin liquids when their tracheostomy tube was not 
occluded. Of these, two showed no signs of aspiration when 
their tracheostomy tubes were occluded. One patient, who 
aspirated both thin liquid and paste consistencies, 
demonstrated no aspiration when his tracheostomy tube was 
occluded; and two patients showed no change or an increase 
in aspiration when their tracheostomy tubes were occluded. 
Specific changes in the biomechanics of swallowing thin 
liquids resulting from tracheal occlusion included: reduced 
duration of base of tongue contact to the posterior 
pharyngeal wall, increased laryngeal elevation, increased 
laryngeal and hyoid elevation at the time of 
cricopharyngeal relaxation, and delayed anterior movement 
of the posterior pharyngeal wall in relation to the onset 
of cricopharyngeal opening. The authors concluded that 
"light" digital occlusion of a tracheostomy tube for 
swallowing was a safe procedure. 
Less encouraging results were observed by Leder and 
associates (1996, 1998). They found that occlusion status 
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of the tracheostomy tube had no effect on the incidence of 
aspiration in two separate studies. Three design flaws are 
noteworthy in those investigations. First, in both studies 
subjects completed the videofluoroscopic swallowing study 
first with their tracheostomy tubes occluded and then with 
their tubes unoccluded. Counterbalancing two conditions 
temporally is important to ensure that one condition does 
not affect the other. Therefore, the subjects should have 
started with their tubes unoccluded. Second, the authors 
state that tubes were sometimes occluded for up to several 
hours prior to the swallowing study, increasing the 
likelihood that fatigue could affect the results. Third, 
the authors only examined videotapes of the swallowing 
studies for the presence or absence of aspiration. They 
did not attempt to quantify aspiration. Therefore, 
although these studies showed that tracheostomy tube 
occlusion did not eliminate aspiration, it is unclear if 
the amount of aspiration, or the specific number of 
aspiration events, was reduced by tube occlusion. 
Passy-Muir Tracheostomy Speaking Valve Placement 
It has also been postulated that the Passy-Muir 
Tracheostomy Speaking Valve may improve swallow function in 
tracheostomized patients. The valve was initially designed 
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to provide a way for tracheostomized patients to phonate. 
Specifically, the valve operates with a positive closure 
valve mechanism, which opens only during inspiration. When 
the valve is closed, and the tracheostomy cuff is deflated, 
air is shunted around the tracheostomy tube and is allowed 
to flow upward through the vocal folds, allowing them to 
vibrate and produce voicing. In addition to allowing the 
patient to phonate, the Passy-Muir Tracheostomy Speaking 
Valve has been shown to have other positive effects, 
including decreased oral and nasal secretions, increased 
food intake secondary to improved olfaction, and, 
reportedly, increased energy levels (Passy, Baydur, 
Prentice, & Darnell-Neal, 1993). 
Several studies have been conducted to examine the 
effects of Passy-Muir valves on swallowing. Dettelbach, 
Gross, Mahlmann, and Eibling (1995) studied 11 patients 
with various diagnoses, including central neurologic 
disease and partial laryngectomy. Each patient completed a 
modified barium swallow study both with and without the 
Passy-Muir valve. Patients were given thin liquids, thick 
liquids, paste consistencies, and/or cookies. Results 
indicated that all patients exhibited a significant 
reduction in aspiration when the valve was in place. 
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However, the authors failed to control for confounding 
factors such as diagnosis. In addition, the authors did 
not explain how they attempted to quantify amount of 
aspiration. Thus, the reliability of their results is 
questionable. 
Staehler, Hamlet, Choi, and Fleming (1996) obtained 
scintigraphic quantification of aspiration in patients with 
and without the Passy-Muir valve. The 11 patients in their 
study were either pre- or post-treatment for head and neck 
cancer. Scintigraphy was completed in conjunction with a 
modified barium swallow study. Results were consistent 
with Dettelbach and colleagues. Although the Passy-Muir 
valve did not eliminate aspiration for any of the patients, 
it did appear to significantly reduce the amount of 
aspiration. 
Leder (1999) examined the effects of the one-way 
speaking valve on swallowing function in 20 non-ventilator 
dependent tracheostomized patients using fiberoptic 
endoscopy. Subjects were observed swallowing with and 
without the valve in place. The endoscopic examinations 
revealed that all subjects who aspirated without the valve 
in place also aspirated with the valve. All subjects who 
did not aspirate without the valve also did not aspirate 
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with the valve. The author concluded that the incidence of 
aspiration was not affected by use of a one-way valve. 
However, the author did not attempt to quantify the 
severity of aspiration. Thus, it is not clear if the valve 
had any effect on swallowing function. 
The specific effects of the Passy-Muir valve on 
swallow physiology have not been determined. Some believe 
that the valve may help increase subglottal pressure, which 
is diminished when the tracheostomy tube is open. Gross, 
Dettlebach, Zajac, and Eibling (1994) used a 
pneumotachometer and pressure transducer with a patient who 
demonstrated aspiration of thin liquids when his 
tracheostomy tube was open. Specifically, they measured 
subglottal air pressure with the tracheostomy tube open and 
with a Passy-Muir valve in place. Results indicated a ten-
fold increase in subglottal pressure during swallowing with 
the Passy-Muir valve in place as compared with subglottal 
pressure with the tracheostomy tube open. 
SUMMARY OF THE LITERATURE 
Although surgical methods (Snyderman et al., 1994) may 
eliminate aspiration in tracheostomized patients, the loss 
of voice reduces patients' quality of life. Though non-
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invasive methods of decreasing aspiration are available, 
further investigations are required to determine their 
value. One of those methods needing further study is the 
use of the Passy-Muir Tracheostomy Speaking Valve. 
As previously stated, Dettelbach and colleagues (1994) 
did not use a uniform sample and attempted to use 
compensatory swallowing strategies in their study. In 
addition, it is not clear how these authors determined the 
approximate percentage of aspiration; and the reliability 
of their ratings is highly questionable. Several authors 
have investigated inter- and intra-judge reliability in the 
reading of videofluoroscopic swallowing studies (Kuhlemeir, 
Yates, and Palmer, 1998; McCullough, Wertz, Rosenbek, 
Mills, Webb, & Ross, 2001). Reliability for rating 
aspiration is reported with mixed results at best. When 
judgments move from a rating of "present" or "absent" to a 
rating on a three or four point scale, reliability 
typically deteriorates (Kuhlemeir et al., 1998). 
8-POINT PENETRATION-ASPIRATION SCALE 
Rosenbek, Robbins, Roecker, Coyle, and Wood (1996) 
recently developed an 8-point Penetration-Aspiration scale 
(see Table 1), which may now be employed to determine the 
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severity of penetration/aspiration based on the depth the 
bolus travels in the airway and the patient's response. 
Reliability of this scale is high, with the authors 
reporting an interjudge intraclass correlation coefficient 
of .96 and an intrajudge intraclass coefficient ranging 
from .95 to .97. Research has also demonstrated that the 
scale may be used with interval level statistics, a 
methodological advantage that may be employed for treatment 
studies attempting to demonstrate reductions in the 
severity of penetration/aspiration (McCullough, Rosenbek, 
Robbins, Coyle, & Wood, 1998). This scale may be useful in 
demonstrating whether deflating a tracheostomy cuff or 
utilizing a Passy-Muir valve reduces penetration/ 
aspiration. 
PURPOSE OF THE STUDY AND RESEARCH QUESTIONS 
The purpose of this study is to determine whether cuff 
deflation and/or Passy-Muir Tracheostomy Speaking Valve 
placement reduces the incidence and/or severity of 
penetration/aspiration in subjects with tracheostomy tubes. 
The 8-Point Penetration-Aspiration scale was utilized to 
measure potential change in the severity of penetration-
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Material does not enter airway. 
Material enters the airway, remains above 
the vocal folds, and is ejected from the 
airway. 
Material enters the airway, remains above 
the vocal folds, and is not ejected from the 
airway. 
Material enters the airway, contacts the 
vocal folds, and is ejected from the airway. 
Material enters the airway, contacts the 
vocal folds, and is not ejected from the 
airway. 
Material enters the airway, passes below the 
vocal folds, and is ejected either from the 
trachea into the larynx or completely out of 
the airway. 
Material enters the airway, passes below the 
vocal folds, and is not ejected from the 
trachea despite effort. 
Material enters the airway and passes below 
the vocal folds, and no spontaneous effort 
is made to eject it. 
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aspiration. Specifically, the following questions were 
addressed: 
1) Does Passy-Muir Tracheostomy Speaking Valve placement 
reduce the incidence and/or severity of 
penetration/aspiration in subjects with tracheostomy 
tubes? 
2) What, if any, effect does Passy-Muir Tracheostomy 
Speaking Valve placement have on swallow physiology? 
3) Does cuff deflation reduce the incidence and/or severity 
of penetration/aspiration in subjects with tracheostomy 
tubes? 






Eighteen individuals who had tracheostomy tubes and 
who were non-ventilator dependent were invited to 
participate in this study. Fourteen of the eighteen 
participants had cuffed tracheostomy tubes, and four had 
cuffless tracheostomy tubes. Participants were recruited 
from the University of Tennessee Medical Center, Baptist 
Hospital of East Tennessee, and Ft. Sanders Regional 
Medical Center. All participants met the following 
inclusion criteria: 
1) The participant was suspected of having swallowing 
difficulty. This was determined by a bedside swallowing 
evaluation, which was completed by a licensed, certified 
speech-language pathologist. Signs/symptoms of possible 
swallowing difficulty include, but are not limited to, 
coughing after swallowing and "gurgly" vocal quality 
after the swallow. 
2) The participant was able to tolerate cuff deflation (if 
the tracheostomy tube was cuffed) and placement of the 
Passy-Muir Tracheostomy Speaking valve for at least five 
minutes. Tolerance was assessed by obtaining oxygen 
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saturation levels and respiratory rate via pulse 
oximetry. A respiratory therapist was present during the 
initial trial of cuff deflation and Passy-Muir 
valve placement. Because acceptable changes in 
oxygen saturation levels vary from individual to 
individual depending upon diagnosis, a respiratory 
therapist was present to help to determine if a 
patient sufficiently tolerated the procedure. 
Participants were also given an index card that 
said ~stop", and were instructed to hold up the card if 
they became uncomfortable or short of breath. 
3) Participants were awake and alert. 
Patients were excluded from this study if they had a 
history of swallowing difficulty prior to their current 
hospitalization. Participants were given an information 
sheet about the study (see Appendix A), and they were asked 
to sign an informed consent form (see Appendix B). 
Profiles for each participant are presented in Table 
2. Patients presented with a variety of diagnoses, 
including chronic obstructive pulmonary disease (COPD), 
head injury, and status-post coronary artery bypass graft 
(CABG). Seventeen of the eighteen participants had naso-
gastric tubes in place at the time of their swallow study. 
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Table 2: Participant Profiles 
Participant Diagno■i■ Nutrition '!'rach Day■ with Day■ on 
' Size 'l'rach 'l'rach Collar 
1 COPD N-G Tube 6 20 4 
2 CHI N-G Tube 6 9 6 
3 COPD N-G Tube 6 21 8 
4 CHI N-G Tube 8 14 4 
5 CHI N-G Tube 6 15 3 
6 CHI PEG Tube 6 17 5 
7 COPD N-G Tube 6 15 7 
8 CHI N-G Tube 6 5 2 
9 s/p CABG N-G Tube 4 11 9 
10 s/p CABG N-G Tube 6 7 3 
11 CHI N-G Tube 6 13 2 
12 CHI N-G Tube 6 19 4 
13 CHI N-G Tube 6 8 6 
14 ARDS N-G Tube 6 26 19 
15 ARDS N-G Tube 6 25 14 
16 COPD N-G Tube 4 18 15 
17 CHI N-G Tube 6 14 4 
18 s/p AAA N-G Tube 8 29 11 
repair 
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The size of each participant's tracheostomy tube was also 
recorded. 
PROCEDURES 
All participants completed a videofluoroscopic 
swallowing study (GE Model 152000G2). Swallow studies were 
recorded on¾ inch videotape using a Mitsubishi HS U120 
videorecorder. All swallow studies were completed in the 
Department of Radiology, and a Radiologist, a Respiratory 
Therapist, and Speech-Language Pathologist were present at 
each study. Participants completed a series of four 
swallows under three conditions: 1) cuff-inflated, 2) no 
cuff or cuff-deflated, and 3) cuff-deflated with the Passy-
Muir valve in place. Participants whose tracheostomy tubes 
did not have cuffs completed the study under two 
conditions: 1) no cuff or cuff-deflated and 2) Passy-Muir 
valve in place. The order in which each participant 
completed these conditions was randomly assigned. During 
the cuff-inflated condition, all participants' tracheostomy 
cuffs were fully inflated. A Posey Cuffolator was used to 
determine if the participant's cuff was sufficiently 
inflated. The size and type (fenestrated versus non-
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fenestrated) of tracheostomy tube were recorded for each 
participant. 
During the videofluoroscopic swallowing study (VFSS), 
for each of the two (or three) conditions, participants 
were given two presentations each of 5-m.L thin (1 part 
barium powder to 1 part water) and 5-m.L puree (4 parts 
applesauce to 1 part barium powder) as tolerated. All 
participants were fed by the clinician completing the VFSS. 
The liquid and the puree boluses were given by spoon. 
Participants were seated at a 90-degree angle in a Hausted 
chair, and lateral view videofluoroscopic images were 
obtained. A penny was placed at the angle of the 
participant's left jaw to serve as a marker for measuring 
hyolaryngeal movement. The swallowing study was stopped 
if: 
1) a participant exhibited more than trace aspiration of 
thin liquid on two subsequent swallows; 
2) if a subject aspirated any amount of pureed texture; 
3) or if gross aspiration was noted on either consistency 
or quantity. 
The participant then continued the study under the 
remaining conditions. Compensatory strategies were used to 
make management decisions. These strategies were only 
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utilized after the protocol was completed and were not 
included in the data analysis. 
ANALYSIS OF VIDEOFLUOROSCOPIC SWALLOWING STUDIES 
All videofluoroscopic-swallowing studies (VFSS) were 
analyzed by a judge with five years experience in visual-
perceptual analysis of normal and disordered swallowing. 
This judge was blinded to the condition under which each 
swallow was completed. Prior to viewing the participants' 
videotapes, this judge was pre-trained to criterion (90% 
agreement) for each VFSS measure by the principal 
investigator. Each participant's videotape was then 
reviewed. Each swallow was viewed at normal, slowed, and 
frame-by-frame speeds until a confident analysis could be 
made. All swallows were analyzed for the following 
duration measures with the 100 ms timer (see Appendix C): 
begin posterior movement of the bolus, first barium into 
the pharynx, head of the bolus into the pharynx, tail of 
the bolus into the pharynx, begin maximum laryngeal 
elevation, first maximum laryngeal elevation, last maximum 
laryngeal elevation, first maximum anterior hyolaryngeal 
excursion, last maximum hyolaryngeal excursion, hyoid 
return to rest, cricopharyngeal opening, head of the bolus 
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into the cricopharyngeus, tail of the bolus into the 
cricopharyngeus, and cricopharyngeal closure. The time in 
milliseconds at which each point occurred was recorded and 
used to calculate the following duration measures: oral 
transit duration (OTD), stage transition duration (STD), 
pharyngeal transit duration (PTD), duration of hyoid 
maximum elevation (DOHME), duration of hyoid maximum 
anterior excursion (DOHMAE), duration of cricopharyngeal 
opening (DOCPO), and total swallow duration (TSD). 
Definitions for how each measure was calculated are 
provided in Table 3. In order to determine maximum 
hyolaryngeal elevation and anterior movement, still frames 
of each participant's hyolaryngeal structures were traced 
onto overhead transparencies. The distance from resting 
hyoid position to maximum elevation and the distance from 
resting hyoid position to maximum hyoid anterior movement 
were measured in millimeters. In order to determine 
magnification effect of the x-ray, the video image of the 
penny placed on each participant's left mandible was 
traced, and the diameter in millimeters was measured. The 
maximum distance from baseline position of the hyoid to 
maximum movement was then multiplied by the magnification 
correction factor derived from the penny. In other words, 
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Table 3: Swallow Duration Measures 
Measure Definition 
Oral Transit Duration Time from the initiation of posterior 
(OTO) bolus movement to arrival of bolus 
head at the ramus of the mandible. 
Stage Transition Time from first barium at the ramus 
Duration of the mandible (not necessarily the 
(STD) head of the bolus} to the beginning 
of maximum hyoid excursion. 
Pharyngeal Transit Time from arrival of the bolus head 
Duration at the ramus of the mandible to bolus 
(PTO) head entering the CP. 
Duration of Hyoid Time from first frame showing maximum 
Maximum Elevation hyoid elevation to last frame showing 
(DOHME) maximum hyoid elevation. 
Duration of Hyoid Time from first frame showing maximum 
Maximum Anterior anterior hyoid movement to last frame 
Excursion showing maximum anterior hyoid 
(DOHMAE) movement. 
Duration of Time from first frame of CP opening 
Cricopharyngeal to last frame of CP opening. 
Opening 
(DOCPO) 
Total Swallow Time from initiation of posterior 
Duration bolus movement to hyoid return to 
(TSO) rest. 
Taken from JoAnne Robbins, 1992, Personal Contact. 
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if the penny is one-inch wide but appears to be two-inches 
wide on the x-ray, the distance moved by the larynx was 
divided by two in order to correct for the magnification 
from the fluoroscopy (Logemann, 1998). In addition, 
videotapes of the VFSS were analyzed for the presence or 
absence of penetration or aspiration, timing of aspiration 
(before, during, or after the swallow) if present, and 
severity of penetration/aspiration, based on an 8-point 
penetration-aspiration scale. 
RELIABILITY 
Intrajudge reliability was determined by having the 
primary judge re-analyze 20 percent of the participants' 
VFSS, blind to the initial results. The principal 
investigator randomly chose intrajudge reliability tapes. 
Interjudge reliability was determined by having a second 
judge, the principal investigator; evaluate 20 percent of 
the participants' VFSS tapes for all measures. Interjudge 
reliability tapes were chosen randomly. Prior to analyzing 
the videotapes, the primary judge and the principal 
investigator analyzed a videotape of a VFSS of an 
individual not participating in this study and completed 
separate analyses. The two judges reviewed and discussed 
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all swallows on which their measures did not agree. This 
was done until the judges reached 90 percent agreement for 
all measures. The second judge then analyzed the 
videotapes for the duration measures previously described. 
From those recorded times the primary investigator 
calculated OTO, STD, PTO, DOHME, DOHMAE, DOCPO, and TSD. 
In addition, the presence or absence of aspiration based 
upon an 8-point penetration-aspiration scale was 
determined. 
STATISTICAL ANALYSIS 
SPSS 10.0 was used to statistically analyze all of the 
data. A total of 150 swallows (44 cuff-inflated, 54 cuff-
deflated or no cuff, and 52 PMTSV) out of a possible 190 
swallows (56 cuff-inflated, 72 cuff-deflated or no cuff, 
and 72 PMTSV) were analyzed. 
In order to answer the first and third research 
questions, "Does Passy-Muir Tracheostomy Speaking Valve 
placement reduce the incidence and/or severity of 
penetration/aspiration?" and "Does cuff deflation reduce 
the incidence and/or severity of penetration/aspiration?" 
each swallow was analyzed for potential penetration/ 
aspiration. Penetration was defined as "entry of 
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oropharyngeal contents into the larynx above the true vocal 
folds" (Perlman & Schulze-Delrieu, 1997, p. 504); 
aspiration was defined as "the penetration of secretions or 
ingesta below the level of the true vocal folds" (Perlman & 
Schulze-Delrieu, p. 492). Penetration/aspiration was first 
rated as present or absent. Timing of aspiration, before, 
during, or after the swallow, was also noted. Then, in 
order to improve upon previous investigations, an 8-point 
penetration-aspiration scale (Rosenbek et al., 1996) was 
utilized to rate the severity of penetration/ aspiration. 
Swallows of similar bolus size and consistency were 
compared between the three conditions (cuff-inflated, cuff-
deflated or no cuff, PMTSV). Group means were obtained for 
each bolus type under each condition. In order to 
determine if condition (cuff-inflated, cuff-deflated or no 
cuff, and Passy-Muir valve) significantly affected severity 
of penetration/ aspiration, a repeated measures analysis of 
variance (ANOVA) was performed using condition and bolus as 
factors. An alpha level of .05 was used to determine 
significance. 
To answer the second and fourth research questions, 
"What, if any, effect does Passy-Muir Tracheostomy Speaking 
Valve placement have on swallow physiology?" and "What, if 
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any, effect does cuff deflation have on swallow 
physiology?", a number of swallowing transit times were 
calculated (see Table 2). Changes in transit times from 
one condition to the next should provide insight into 
specific biomechanical changes that may result from 
deflating the cuff. In addition, maximum extent of 
hyolaryngeal excursion and oropharyngeal residue were also 
determined. Group means were obtained for each durational 
measure, hyolaryngeal excursion, and oropharyngeal residue 
under each condition for each bolus type. A doubly 
multivariate repeated measures analysis of variance 
(MANOVA) was used to examine the differences between means 
for each condition and bolus type. A significance level of 
.05 was used for all measures. 
To determine inter- and intrajudge reliability, 
Pearson's product moment correlations were computed for all 
duration measures. Kendall's tau correlations were 






Pearson's product moment correlations were computed 
for all duration measures. Kendall's tau correlations were 
computed for scores on the Penetration-Aspiration scale and 
for oropharyngeal residue. Results for interjudge and 
intrajudge reliability for all duration measures, scores on 
the Penetration-Aspiration scale, and oro-pharyngeal 
residue are presented in Table 4. Correlations for 
interjudge reliability ranged from .915 to 1.000. 
Correlations for intrajudge reliability ranged from .906 to 
1.000. 
PASSY-MUIR TRACHEOSTOMY SPEAKING VALVE 
Penetration-Aspiration 
The answer to the first research question, "Does 
Passy-Muir Tracheostomy Speaking Valve (PMTSV) placement 
reduce the incidence or severity of aspiration?", is yes. 
Number of penetration/aspiration occurrences and mean 
scores on the Penetration-Aspiration scale were determined. 
Results are presented in Table 5. Penetration without 
36 





Measure Correl.ation Significance Correl.ation Significance 
OTO .963* .037 
STD .954* .046 
PTO .996* .004 
DOHME .979* .021 
DOHMAE .915* .085 
DOCPO .943* .057 
TSO . 964* .036 
P-A .993** .007 
Oral Residue 1. 000** .042 
Vallecular .954** .046 
Residue 
PPW Residue .951** .049 
Pyriform Sinus 1. 000** .000 
Residue 
C-P Residue 1. 000** .000 
Pearson's product moment correlation 
Kendall's tau correlation 
.906* .000 
• 976* .000 












Table 5: Penetration-Aspiration 
Condition Bolus Number of Number of Mean P-A 
Penetration Aspiration Scale 
Occurrences Occurrences Score 
Cuff Liquid 2 15 6.571 
Inflated 
No Cuff or 
Cuff Liquid 5 16 6.111 
Deflated 
PMTSV Liquid 7 4 3.056 
Cuff Pureed 2 2 2. 623 
Inflated 
No Cuff or Pureed 1 4 2.366 
Cuff 
Deflated 
PMTSV Pureed 3 2 2.585 
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aspiration of the liquid bolus occurred with the following 
frequency: cuff-inflated= 2, no cuff or cuff-deflated= 5, 
PMTSV = 7. Penetration without aspiration of the pureed 
bolus occurred with the following frequency: cuff-inflated 
= 2, no cuff or cuff-deflated= 1, PMTSV = 3. Aspiration 
of the liquid bolus was noted with the following frequency: 
cuff-inflated= 15, no cuff or cuff-deflated= 16, PMTSV = 
4. Aspiration of the pureed bolus was noted with the 
following frequency: cuff-inflated= 2, no cuff or cuff-
deflated = 4, PMTSV = 2. Aspiration was most frequently 
noted during the swallow (40 of 43 occurrences). The 
majority of aspiration occurrences, 37 of 43, were silent. 
The 8-point Penetration-Aspiration scale was utilized 
to determine severity of penetration-aspiration. The mean 
score on the Penetration-Aspiration scale with the cuff 
inflated was 6.571 (Standard Error (S.E.) = .462) for the 
liquid bolus and 2.623 (S.E. = .745) for the pureed bolus. 
The mean score on the Penetration-Aspiration scale for the 
cuff-deflated or no cuff condition was 6.111 (S.E. = .667) 
for the liquid bolus and 2.366 (S.E. = .542) for the pureed 
bolus. For the PMTSV condition, the mean score on the 
Penetration-Aspiration scale was 3.056 (S.E. = .639) for 
the liquid bolus and 2.585 (S.E. = .705) for the pureed 
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bolus. A 2 (condition) x 2 (bolus) repeated-measures 
analyses of variance (ANOVA) (p ~ .05) was employed to 
examine the differences in mean Penetration-Aspiration 
scale scores for the no-cuff or cuff-deflated condition and 
the PMTSV condition (see Table 6). Results revealed a 
significant main effect of condition (f(l, 17) = 8.042, p = 
.011) and bolus (f(l, 17) = 8.112, p = .011). There was 
also a significant interaction between condition and bolus 
(f(l, 17) = 8.834, p = .009). To further examine the 
interaction between condition and bolus, a repeated-
measures ANOVA (p ~ .05) was performed for each bolus under 
each condition. Results for the liquid bolus revealed a 
significant main effect for condition (F(l, 17) = 18.204, 
p = .001). Results for the pureed bolus revealed no 
significant main effect for condition (f(l, 17) = .081, 
p = .779). For the liquid bolus, scores on the 
Penetration-Aspiration scale were significantly lower 
(better) for PMTSV condition than for the no cuff or cuff-
deflated condition. 
For the fourteen individuals who had cuffed 
tracheostomy tubes, a 2 (condition) x 2 (bolus) repeated-
measures ANOVA (p ~ .05) was employed in order to examine 
the differences in mean Penetration-Aspiration scale scores 
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Table 6: Repeated Measures Analysis of Variance for 
Penetration-Aspiration-No Cuff or Cuff Deflated 
versus Passy-Muir Valve 
Independent Measure df F Significance Error df 
Condition 1.000 8.042 .011* 17.000 
Bolus 1.000 8.112 .011* 17.000 
Condition x Bolus 1. 000 8.834 .009* 17.000 
*Value is significant at p < .05. 
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for the cuff-inflated and PMTSV conditions (see Table 7). 
Results revealed a significant main effect of condition 
(f(l, 13) = 16.345, p = .001) and bolus (f(l, 13) = 56.254, 
p < .001). Scores on the Penetration-Aspiration scale were 
significantly lower (better) for the PMTSV condition than 
for the cuff-inflated condition. In addition, scores on 
the Penetration-Aspiration scale were significantly lower 
for the pureed bolus than for the liquid bolus. 
Swallowing Physiology 
The answer to the second research question, "Does 
Passy-Muir Tracheostomy Speaking Valve placement affect 
swallow physiology?", appears to be no. Means were derived 
for all duration measures, extent of hyolaryngeal 
excursion, and residue. 
Duration .Measures 
Mean values for all duration measures are presented in 
Table 8. A two-factor (condition and bolus) doubly 
multivariate repeated-measures analysis of variance 
(MANOVA) (p ~ .05) (see Table 9) was employed to examine 
differences in means for duration measures for the no cuff 
or cuff-deflated condition and the PMTSV condition. 
Results revealed no significant main effect of condition (f 
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Tabla 7: Repeated Measures Analysis of Variance for 
Penetration-Aspiration-Cuff Inflated versus 
Passy-Muir Valve 
Independent Measure df F Significance Error df 
Condition 1.000 16.345 .001* 13.000 
Bolus 1.000 56.254 .000* 13.000 
Condition x Bolus 1.000 2.626 .129 13.000 
*Value is significant at p < .05. 
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Table 8: Mean Duration Measures (in milliseconds) 
Measure Condition Bolus Mean Standard 
Error 
Oral Transit Cuff Inflated Liquid 1.190 .344 
Duration Puree 2.316 .740 
No Cuff or Liquid 1.273 .508 
Cuff Deflated Puree 3.837 1.057 
PMTSV Liquid 1.067 .444 
Puree 1.709 .387 
Stage Transition Cuff Inflated Liquid -.009 .016 
Duration Puree -.012 .030 
No Cuff or Liquid -.009 .011 
Cuff Deflated Puree -.014 .015 
PMTSV Liquid .018 .016 
Puree -.059 .011 
Pharyngeal Transit Cuff Inflated Liquid .207 .018 
Duration Puree .260 .054 
No Cuff or Liquid .174 .017 
Cuff Deflated Puree .186 .015 
PMTSV Liquid .169 .015 
Puree .197 .020 
Duration of Hyoid Cuff Inflated Liquid .284 .045 
Maximum Elevation Puree .296 .037 
No Cuff or Liquid .361 .054 
Cuff Deflated Puree .332 .037 
PMTSV Liquid .313 .042 
Puree .281 .037 
Duration of Cuff Inflated Liquid .527 .029 
Cricopharyngeal Puree .567 .049 
Opening No Cuff or Liquid .433 .038 
Cuff Deflated Puree .524 .038 
PMTSV Liquid .516 .064 
Puree .474 .029 
Total Swallow Cuff Inflated Liquid 1.977 .335 
Duration Puree 3.182 .713 
No Cuff or Liquid 2.046 .494 
Cuff Deflated Puree 2.717 .524 
PMTSV Liquid 1. 825 .429 
Puree 2.375 .379 
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Table 9: Doubly Multivariate Repeated Measures Analysis of 
Variance for Swallow Duration Measures-No Cuff or 
Cuff Deflated versus Passy-Muir Tracheostomy 
Speaking Valve 
Independent Measure df F Significance Error df 
Condition 7.000 1.316 .328 11.000 
Bolus 7.000 2.684 .070 11.000 
Condition x Bolus 7.000 1.419 .290 11. 000 
*Value is significant at p < .05. 
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(7, 11) = 1.316, p = .328) or bolus (f(7, 11) = 2.684, 
p = .070). 
For the fourteen individuals who had cuffed 
tracheostomy tubes, a two-factor (condition and bolus) 
doubly multivariate repeated- measures analysis of variance 
(MANOVA) (p < .05) (see Table 10) was employed to examine 
the differences in means for duration measures for the 
cuff-inflated condition and the PMTSV condition. Results 
revealed no significant main effect for condition (f(7, 7) 
= 1.817, p = .225) or for bolus (f(7, 7) = 1.773, p = 
.234). 
Hyolaryngeal Excursion 
Mean values for maximum laryngeal elevation and 
maximum hyoid anterior excursion are presented in Table 11. 
Mean maximum laryngeal elevation for the cuff-inflated 
condition was 9.853 mm (S.E. = .763) for the liquid bolus 
and 9.023 mm (S.E. = .717) for the pureed bolus. For the 
cuff-deflated condition, mean maximum laryngeal elevation 
was 9.224 mm (S.E. = .763) for the liquid bolus and 8.840 
mm (S. E. = .489) for the pureed bolus. For the PMTSV 
condition, mean laryngeal elevation was 8.493 mm (S. E. = 
.718) for the liquid bolus and 9.569 mm (S. E. = .718) for 
the pureed bolus. A 2 (condition) x 2 (bolus) univariate 
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Table 10: Doubly Multivariate Repeated Measures Analysis of 
Variance for Swallow Duration Measures~uff 
Inflated versus Passy-Muir Tracheostomy 
Speaking Valve 
Independent Measure df F Significance Error df 
Condition 7.000 1. 817 .225 7.000 
Bolus 7.000 1. 773 .234 7.000 
Condition x Bolus 7.000 1.278 .377 7.000 
*Value is significant at p < .05. 
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Table 11: Mean Values for Hyolaryngeal Excursion (in 
millimeters) 
Measure Condition Bolus Mean Standard 
Error 
Cuff Inflated Liquid 9.853 .763 
Maximum Laryngeal Puree 9.023 .717 
Elevation No Cuff or Liquid 9.224 .763 
Cuff Deflated Puree 8.840 .489 
PMTSV Liquid 8.493 .718 
Puree 9.569 .718 
Cuff Inflated Liquid 11.350 .635 
Maximum Hyoid Puree 9.314 .908 
Anterior No Cuff or Liquid 11. 671 .834 
Excursion Cuff Deflated Puree 10.654 .570 
PMTSV Liquid 10.736 .866 
Puree 11. 465 .734 
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repeated-measures analysis of variance (ANOVA) (p ~ .05) 
was employed to examine the differences in mean laryngeal 
elevation for the no cuff or cuff-deflated condition and 
the PMTSV condition (see Table 12). Results revealed no 
significant main effect for condition (f(l, 17) = .000, p = 
.996) or bolus (f(l, 17) = .271, p = .609). A separate 
univariate repeated measures analysis of variance (ANOVA) 
(p < .05) was employed to examine the differences in means 
for laryngeal elevation for the cuff-inflated condition and 
the PMTSV condition (see Table 13). Results revealed no 
significant main effect of condition (f(l, 13) = .297, p = 
.595) or bolus (f(l, 13) = .010, p = .920). 
Mean hyoid anterior movement for the cuff-inflated 
condition was 11.350 mm (S. E. = .635) for the liquid bolus 
and 9.314 mm (S.E. = .908) for the pureed bolus. For the 
no cuff or cuff-deflated condition, mean hyoid anterior 
movement was 11.671 mm (S.E. = .834) for the liquid bolus 
and 10.654 mm (S.E. = .570) for the pureed bolus. Mean 
maximum hyoid anterior movement for the PMTSV condition was 
10.736 mm (S.E. = .866) for the liquid bolus and 11.465 mm 
(S.E. = .734) for the pureed bolus. A 2 (condition) x 2 
(bolus) univariate repeated-measures analysis of variance 
(ANOVA) (p < .05) was performed to examine the differences 
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Table 12: Univariate Repeated Measures Analysis of 
Variance for Laryngeal Elevation-No Cuff or Cuff 
Deflated versus Passy-Muir Tracheostomy 
Speaking Valve 
Independent Measure df F Significance Error df 
Condition 1. 000 .000 .996 17.000 
Bolus 1. 000 .271 .609 17.000 
Condition x Bolus 1. 000 2.833 .111 17.000 
*Value is significant at p < .05. 
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Table 13: Univariate Repeated Measures Analysis of 
Variance for Laryngeal Elevation~uff 
Inflated versus Passy-Muir Tracheostomy 
Speaking Valve 
Independent Measure df F Significance Error df 
Condition 1. 000 .297 .595 13.000 
Bolus 1.000 .010 .920 13.000 
Condition x Bolus 1.000 1.451 .250 13.000 
*Value is significant at p < .05. 
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in mean hyoid anterior movement for the no cuff or cuff-
deflated condition and the PTMSV condition. Results 
indicated no significant main effect for condition (f(l, 
17) = .019, p = .892) or bolus (f(l, 17) = .051, p = .825. 
To examine the differences in mean hyoid anterior movement 
for the cuff-inflated condition and PMTSV condition, a 
separate 2 (condition) x 2 (bolus) univariate repeated-
measures analysis of variance (ANOVA) (p ~ .05) was 
performed. Results indicated no significant main effect of 
condition (f(l, 13) = 2.832, p = .116). There was a 
significant main effect for bolus (f(l, 13) = 4.955, p = 
.044). Specifically, maximum hyoid anterior movement was 
significantly greater for the liquid bolus than for the 
puree bolus. 
Residue 
Residue was rated using a 3-point scale: 0 = "no 
visible residue"; 1 = "coating"; and 2 = "pooling". 
Residue in the oral cavity, valleculae, posterior 
pharyngeal wall, pyriform sinuses, and the cricopharyngeus 
was noted. Mean values for residue are presented in Table 
14. A two-factor (condition and bolus) doubly multivariate 
repeated-measures analysis of variance (MANOVA) (p ~ .05) 
(see Table 15) was performed to examine the differences in 
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Table 14: Mean Values for Oropharyngeal Residue 
Location Condition Bolus Mean Standard 
Error 
Oral Cavity Cuff Inflated Liquid .885 .151 
Puree .952 .183 
No Cuff or Liquid 1.029 .145 
Cuff Deflated Puree 1.100 .098 
PMTSV Liquid 1.118 .163 
Puree 1.426 .190 
Valleculae Cuff Inflated Liquid 1.038 .174 
Puree 1.338 .207 
No Cuff or Liquid 1.118 .163 
Cuff Deflated Puree 1.366 .157 
PMTSV Liquid 1.206 .177 
Puree 1. 740 .140 
Posterior Cuff Inflated Liquid .231 .108 
Pharyngeal Wall Puree .354 .130 
No Cuff or Liquid .206 .096 
Cuff Deflated Puree .219 .093 
PMTSV Liquid .441 .120 
Puree .561 .192 
Pyriform Sinus Cuff Inflated Liquid .538 .215 
Puree .803 .231 
No Cuff or Liquid .647 .195 
Cuff Deflated Puree .585 .186 
PMTSV Liquid .706 .227 
Puree .930 .229 
Cricopharyngeus Cuff Inflated Liquid .000 .000 
Puree .177 .104 
No Cuff or Liquid .147 .083 
Cuff Deflated Puree .257 .094 
PMTSV Liquid .235 .097 
Puree .152 .125 
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Table 15: Doubly Multivariate Repeated Measures Analysis of 
Variance for Oropharyngeal Residue-No Cuff or 
Cuff Deflated versus Passy-Muir Tracheostomy 
Speaking Valve 
Independent Measure df F Significance Error df 
Condition 5.000 2.331 .102 13.000 
Bolus 5.000 1. 693 .206 13.000 
Condition x Bolus 5.000 1.110 .402 13.000 
*Value is significant at p < .05. 
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mean values for residue for the no cuff or cuff-deflated 
condition and the PMTSV condition. Results revealed no 
significant main effect for condition (f(5, 13) = 2.331, 
p = .102) or bolus (f(5, 13) = 1.693, p = .206). A 
separate two-factor (condition and bolus) doubly 
multivariate repeated-measures analysis of variance 
(MANOVA) (p ~ .05) (see Table 16) was performed to examine 
the differences in means for residue for the cuff-inflated 
condition and the PMTSV condition. Results revealed a 
significant main effect of condition (f(5, 9) = 10.280, p = 
.002). Univariate testing revealed a significant effect of 
condition on oral residue (f(l, 13) = 13.760, p = .003), 
posterior pharyngeal wall residue (F(l, 13) = 5.799, p = 
.032), and cricopharyngeal residue (f(l, 13) = 5.452, p = 
.036). Specifically, residue in the oral cavity, posterior 
pharyngeal wall residue, and cricopharyngeus was 
significantly greater for the PMTSV condition than for the 
cuff-inflated condition. Bolus type also had a significant 
effect on oropharyngeal residue (f(5, 9) = 4.207, p = 
.030). Residue in the valleculae was significantly greater 
for the pureed bolus than for the liquid bolus (f(l, 13) = 
14.694, p = .002). 
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Table 16: Doubly Multivariate Repeated Measures Analysis of 
Variance for Oropharyngeal Residue-Cuff Inflated 
versus Passy-Muir Tracheostomy Speaking Valve 
Independent Measure df F Significance Error df 
Condition 5.000 10.280 .002* 9.000 
Bolus 5.000 4.207 .030* 9.000 
Condition x Bolus 5.000 .354 .868 9.000 
*Value is significant at p < .05. 
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CUFF DEFLATION 
To answer the third and fourth research questions, 
data from the 14 participants who had cuffed tracheostomy 
tube was analyzed. 
Penetration-Aspiration 
The answer to the third research question, "Does cuff 
deflation reduce the incidence and/or severity of 
penetration/aspiration in tracheostomized patients?", is 
no. The mean score on the Penetration- Aspiration scale 
for the cuff-inflated condition was 6.571 (S.E. = .462) for 
the liquid bolus and 2.623 (S.E. = .745) for the pureed 
bolus. For the cuff-deflated condition, the mean score on 
the Penetration-Aspiration scale was 6.321 (S.E. = .741) 
for the liquid bolus and 2.181 (S.E. = .544) for the pureed 
bolus. To determine if these means were statistically 
different, a 2 (condition) x 2 (bolus) repeated measures 
analysis of variance (ANOVA) (p ~ .05) was performed (see 
Table 17). Results indicated no significant main effect of 
condition (F(l, 13) = .518), p = .484). There was a 
significant main effect for bolus (f(l, 13) = 48.497, p < 
.001). Scores on the Penetration-Aspiration scale were 
significantly lower (better) for the pureed bolus than for 
the liquid bolus. 
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Table 17: Repeated Measures Analysis of Variance for 
Penetration-Aspiration-Cuff Inflated versus Cuff 
Deflated 
Independent Measure df F Significance Error df 
Condition 1.000 .518 .484 13.000 
Bolus 1.000 48.497 .000* 13.000 
Condition x Bolus 1.000 .053 .821 13.000 
*Value is significant at p < .05. 
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Swallowing Physiology 
The answer to the fourth research question, "Does cuff 
deflation affect swallowing physiology?" is yes. Means 
were derived for all duration measures, extent of 
hyolaryngeal excursion, and residue. 
Duration .Measures 
A two-factor (condition and bolus) doubly multivariate 
repeated-measures analysis of variance (MANOVA) (p ~ .05) 
revealed a significant main effect for condition (I(7, 7) = 
3.852, p = .048) on swallowing duration measures(see Table 
18). Univariate testing (p ~ .05) revealed a significant 
effect for condition on pharyngeal transit duration (PTO) 
(F(l, 13) = 5.487, p = .036), duration of hyoid maximum 
anterior excursion (DOHMAE) (I(l, 13) = 4.719, p = .049) 
and duration of cricopharyngeal opening (I(l, 13) = 4.719, 
p = .005) (DOCPO). Specifically, mean PTO was 
significantly longer for the cuff-deflated condition than 
for the cuff-inflated condition, mean DOHMAE was 
significantly longer for the cuff-deflated condition than 
for the cuff-inflated condition, while mean DOCPO was 
significantly shorter for the cuff-deflated condition than 
for the cuff-inflated condition. There was no significant 
main effect of bolus (I(7, 7) = 2.316, p = .145). 
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Table 18: Doubly Multivariate Repeated Measures Analysis of 
Variance for Swallow Duration Measures-Cuff 
Inflated versus Cuff Deflated 
Independent Measure df F Significance Error df 
Condition 7.000 3.852 .048* 7.000 
Bolus 7.000 2.316 .145 7.000 
Condition x Bolus 7.000 1.340 .355 7.000 
*Value is significant at p < .05. 
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Hyolaryngeal Excursion 
Mean maximum laryngeal elevation for the cuff-inflated 
condition was 9.853 mm (S.E. = .763) for the liquid bolus 
and 9.023 mm (S.E. = .717) for the pureed bolus. For the 
cuff-deflated condition, mean maximum laryngeal elevation 
was 9.656 mm (S.E. = .944) for the liquid bolus and 8.942 
mm (S.E. = .408) for the pureed bolus. A 2 (condition) x 2 
(bolus) univariate repeated-measures analysis of variance 
(ANOVA) (p ~ .05) revealed no significant effect of 
condition (f(l, 13) = .159, p = .696) or bolus (f(l, 13) = 
2.805, p = .118) (see Table 19). 
Mean distance for maximum hyoid anterior excursion for 
the cuff-inflated condition was 11.350 mm (S.E. = .635) for 
the liquid bolus and 9.314 mm (S.E. = .908) for the pureed 
bolus. For the cuff-deflated condition, mean maximum hyoid 
anterior excursion was 12.076 mm (S.E. = 1.002) for the 
liquid bolus and 11.055 mm (S.E. = .642) for the pureed 
bolus. A 2 (condition) x 2 (bolus) univariate repeated-
measures ANOVA (p ~ .05) revealed a significant main effect 
for condition (f(l, 13) = 7.960, p = .014) (see Table 20). 
Mean maximum hyoid anterior movement was significantly 
greater for the cuff-deflated condition than for the cuff-
inflated condition. 
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Table 19: Univariate Repeated Measures Analysis of 
Variance for Laryngeal Elevation-Cuff Inflated 
versus Cuff Deflated 
Independent Measure df F Significance Error df 
Condition 1.000 .159 .696 13.000 
Bolus 1.000 2.805 .118 13.000 
Condition x Bolus 1.000 .008 .930 13.000 
*Value is significant at p < .05. 
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Table 20: Univariate Repeated Measures Analysis of 
Variance for Anterior Hyoid Movement-Cuff 
Inflated versus Cuff Deflated 
Independent Measure df F Significance Error df 
Condition 1.000 7.960 .014* 13.000 
Bolus 1.000 32.379 .000* 13.000 
Condition x Bolus 1.000 .274 .610 13.000 
*Value is significant at p < .05. 
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Residue 
Residue was rated using a 3-point scale: 0 = "no 
visible residue"; 1 = "coating"; and 2 = "pooling." 
Residue in the oral cavity, valleculae, posterior 
pharyngeal wall, pyriform sinuses, and the cricopharyngeus 
was noted. A two-factor (condition and bolus) doubly 
multivariate repeated-measures analysis of variance 
(MANOVA) (p ~ .05) revealed no significant effect for 
condition (F(S, 9) = 2.398, p = .120) or bolus (f(S, 9) = 
1.909, p = .188) on residue (see Table 21). 
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Table 21: Doubly Multivariate Repeated Measures Analysis of 
Variance for Oropharyngeal Residue-<:uff Inflated 
Versus Cuff Deflated 
Independent Measure df F Significance Error df 
Condition 5.000 2.398 .120 9.000 
Bolus 5.000 1.909 .188 9.000 
Condition x Bolus 5.000 .701 .637 9.000 




Many physicians believe that an inflated tracheostomy 
tube cuff will prevent spillage of material into the lower 
airway. Thus, tracheostomy tubes are often placed as a 
means of treating chronic aspiration. There is substantial 
evidence in the literature that suggests tracheostomy tubes 
adversely affect swallowing function. Nash (1988) stated, 
~the major swallowing disorder associated with tracheostomy 
is aspiration" (p. 705). 
Several investigators (Dettelbach et al., 1995; 
Staehler et al., 1996) have suggested that Passy-Muir 
Tracheostomy Speaking Valve (PMTSV) placement may reduce 
the incidence and severity of aspiration in tracheostomized 
patients. Dettelbach and colleagues examined the effects 
of PMTSV placement on swallow function in 11 
tracheostomized individuals using videofluoroscopy. They 
found that all 11 participants exhibited a marked reduction 
in the incidence and amount of aspiration when the PMTSV 
was in place. However, the authors did not specifically 
state how they determined the amount of aspiration. Thus, 
the results of their study are questionable. 
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Staehler and associates (1996) also examined the 
effects of PTMSV placement on incidence and severity of 
aspiration in tracheostomized patients. They used 
scintigraphy in conjunction with videofluoroscopy. Results 
of their study indicated that while the PMTSV did not 
eliminate aspiration for any of the participants, it did 
appear to reduce the amount of aspiration. 
While these two studies suggest that the Passy-Muir 
valve has a positive effect on swallow function, there have 
been conflicting findings reported in the literature. 
Leder (1999) examined 20 tracheostomized individuals using 
fiberoptic endoscopy. Swallow function was examined with 
and without a one-way valve in place. Results indicated 
that placement of a one-way valve had no significant effect 
on the incidence of aspiration in tracheostomized 
individuals. 
The purpose of the current study was to examine the 
effect of Passy-Muir Tracheostomy Speaking Valve placement 
on the incidence and severity of aspiration in 
tracheostomized individuals. An 8-point penetration-
aspiration scale was used to rate the severity of 
penetration/aspiration events. Fourteen individuals with 
cuffed tracheostomy tubes and four individuals with 
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cuffless tracheostomy tubes were examined. Results 
indicate that the PMTSV significantly reduces the severity 
of penetration/aspiration. These results support previous 
findings in the literature that suggest that PMTSV 
placement reduces the incidence of aspiration in 
tracheostomized patients. 
In order to determine how the Passy-Muir valve 
affected specific biomechanical aspects of the swallow, a 
number of swallow duration measures were calculated. In 
addition, maximum extent of hyolaryngeal excursion and 
amount of oropharyngeal residue were determined. Results 
of this study indicate that, when compared to the cuff-
inflated condition, the PMTSV resulted in an increase in 
oral residue, posterior pharyngeal residue, and 
cricopharyngeal residue. The reason for the increase in 
oropharyngeal residue is unclear. Logemann, Pauloski, and 
Coleangelo (1998) found that tracheostomy tube occlusion 
reduced duration of tongue base contact to the posterior 
pharyngeal wall. It is possible that this also occurred 
with the participants in the current study. 
None of the findings related to swallow physiology 
would account for the significant reduction in incidence 
and severity of aspiration that was evident in this study. 
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Several studies (Gross et al., 1994; Sasaki & Isaacson, 
1988) have found that the presence of a tracheostomy tube 
results in a reduction in subglottal air pressure. Eibling 
and Gross (1996) have suggested that reduction in 
subglottal air pressure in the primary mechanism 
responsible for aspiration in tracheostomized patients. 
Gross and colleagues found that PMTSV placement results in 
a significant increase in subglottal air pressure. The 
current study did not examine subglottal air pressure. 
In addition, by allowing air to flow through the upper 
airway, PMTSV placement may improve pharyngeal sensation. 
Improved pharyngeal sensation could result in improved 
bolus control and safer swallow function. Pharyngeal 
sensation was not examined in this study. 
Another aim of this study was to examine the effects 
of cuff deflation on incidence and severity of 
penetration/aspiration. Several investigators (Bonnano, 
1971; Elpern, Scott, Petro, & Ries, 1994; Logemann, 1995; 
Murray & Brzozowski, 1998) have suggested that the presence 
of an inflated tracheostomy cuff may interfere with normal 
swallowing function. An inflated tracheostomy tube cuff 
may impede hyolaryngeal excursion, resulting in reduced 
airway protection and decreased cricopharyngeal opening. 
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Delayed onset of the pharyngeal swallow and the presence of 
pharyngeal residue have frequently been observed in 
patients with cuffed tracheostomy tubes who have no 
additional medical condition that would predispose them to 
swallowing dysfunction (Murray & Brzozowski). Tracheostomy 
cuffs do not provide a perfect tracheal seal, and patients 
can and do aspirate around an inflated cuff. Moreover, if 
the cuff is improperly inflated, the cuff may impinge on 
the esophageal wall, effectively preventing the flow of 
food or liquid through the esophagus. Repeated swallowing 
with an over-inflated cuff may also create a tracheo-
esophageal fistula. 
Given the detrimental effects of inflated tracheostomy 
cuffs on swallowing, one might speculate that deflating the 
cuff would restore normal swallowing function. Tippett and 
Siebens (1991) sought to determine if this was the case. 
They examined five ventilator-dependent, tracheostomized 
patients with various diagnoses. Swallowing function was 
examined in three of the five patients using 
videofluoroscopy. All three of these patients were 
receiving a non-oral means of nutrition. Individuals were 
first assessed with their tracheostomy cuffs inflated and 
then re-assessed at a later date with their cuffs deflated. 
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The second videofluoroscopic swallow study (VFSS) was 
postponed until each participant was able to phonate with 
the cuff deflated. Length of time from the initial VFSS 
and the second VFSS ranged from 10 to 28 days. All 
individuals were able to safely swallow with their cuffs 
deflated. However, for two of the individuals, penetration 
was only eliminated when their tracheostomy tube was 
coupled to a ventilator. The authors concluded that 
deflating a tracheostomy tube cuff "restores safe oral 
alimentation by mouth" (p.94). Two design flaws are 
noteworthy. First, because there were a substantial number 
of days between the initial and second VFSS, any changes in 
swallowing function may not be attributed solely to cuff 
deflation. In addition, individuals were ventilator-
dependent. In fact, two of the three participants were 
only able to safely take food by mouth when their 
tracheostomy tubes were coupled to a ventilator. Thus, it 
appears that the ventilator, not cuff deflation, may have 
been responsible for any improvements in swallowing. 
This study also examined the effect of cuff deflation 
on the incidence and severity of aspiration. Fourteen non-
ventilator dependent patients participated. No significant 
differences were observed between cuff-inflated and cuff-
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deflated conditions on incidence or severity of aspiration. 
There are two potential reasons for the discrepancy between 
our findings and the results reported by Tippett and 
Siebens (1991). As previously stated, patients in Tippett 
and Siebens' study were ventilator-dependent. Thus, the 
ventilator may have affected swallowing function more than 
cuff deflation. The individuals in our study were off the 
ventilator in order to eliminate any possible interference. 
Second, the cuff-inflated and cuff-deflated conditions were 
completed during the same VFSS study rather than during 
separate studies in order to eliminate possible time 
effects; and conditions were randomized to reduce the 
possibility of an order effect. 
It is unclear why cuff deflation had no apparent 
effect on the incidence of penetration/aspiration. 
Deflating the cuff does not resolve the problem of reduced 
subglottal pressure created by the presence of a 
tracheostomy tube. As previously stated, Eibling and Gross 
(1996) have suggested that reduction in subglottal air 
pressure is the primary mechanism responsible for 
aspiration in tracheostomized patients. Additionally, 
tracheostomy tubes have been found to increase the sensory 
threshold of the adductor vocal fold reflex (Buckwalter & 
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Sasaki, 1984). Although cuff deflation restores airflow 
through the vocal folds and upper airway, some air is still 
allowed to escape through the open tracheostomy tube. 
Thus, cuff deflation may not fully restore sensation in the 
pharynx and larynx, which is necessary for safe swallowing. 
We did not attempt to assess laryngeal or pharyngeal 
sensation in this study. 
Cuff deflation was observed to significantly increase 
pharyngeal transit duration (PTD), duration of hyoid 
maximum anterior excursion (DOHMAE) and significantly 
reduce duration of cricopharyngeal opening (DOCPO). In 
addition, maximum hyoid anterior movement (mm) was 
significantly increased by cuff deflation. The findings of 
increased DOHMAE and increased maximum hyoid anterior 
movement support the suggestion that an inflated 
tracheostomy tube cuff reduces hyolaryngeal excursion. It 
is unclear why there was a reduction in DOCPO. All but one 
participant had a nasogastric tube in place at the time of 
their swallow examination. Perhaps, as Gilbert and 
colleagues (1987) suggested, the presence of a nasogastric 
tube interferes with relaxation of the cricopharyngeal 
sphincter. The reason for increased PTD is uncertain. 
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Conclusions and Clinical Implications 
The major findings of this study indicate that Passy-
Muir Tracheostomy Speaking valve placement significantly 
reduces the incidence and severity of aspiration in 
tracheostomized patients. Swallow duration measures and 
hyolaryngeal excursion were not significantly affected by 
Passy-Muir valve placement. Thus, the reason for the 
reduction in penetration/aspiration remains unclear. 
This study has important implications for clinicians 
working with tracheostomized patients. Findings suggest 
that patients who are able to tolerate cuff deflation and 
Passy-Muir Tracheostomy Speaking valve placement may 
benefit from eating with a Passy-Muir valve in place. 
Clinicians who complete videofluoroscopic swallow 
evaluations with tracheostomized patients should include 
several bolus presentations with the Passy-Muir valve in 
place. 
Limitations 
There are several limitations of the present study. 
First, a power analysis completed prior to the initiation 
of this study indicated that 22 participants were necessary 
in order to achieve a power of .95. However, only 18 
participants met the inclusion criteria for this study. 
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Scores on the Penetration-Aspiration scale for the cuff-
inflated condition versus the Passy-Muir valve condition 
and for the cuff-deflated condition versus the Passy-Muir 
valve condition were found to significantly differ. Since 
statistical significance was found, there would be no gain 
made by adding four additional participants. However, the 
fact that we only included 18 participants rather than 22 
may account for the lack of statistical significance found 
for the swallow duration measures and hyolaryngeal 
excursion when comparing the cuff-inflated condition and 
the PMTSV condition and when comparing the cuff-deflated 
condition to the PMTSV condition. 
In addition, we did not attempt to control for length 
of time between tracheostomy tube placement and the 
videofluoroscopic swallow study (VFSS). Nor did we attempt 
to control for length of time between initial cuff 
deflation and the VFSS. Finally, we did not attempt to 
control for participants' diagnoses, though we did ensure 
all participants were free of structural damage other than 
tracheotomy. 
Future Research 
The findings from the present study suggest the need 
for further research to investigate the effects of 
75 
tracheostomy tubes on swallowing physiology. Specifically, 
the effect of the Passy-Muir valve on pharyngeal and 
laryngeal sensitivity needs to be assessed. An 
investigation designed to determine the effects of Passy-
Muir valve placement on subglottal pressure may elucidate 
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Information Sheet 
An Examination of the Effects of Passy-Muir Tracheostomy Speaking Valve 
Placement on Incidence and Severity of Aspiration in Tracheostomized Patients 
You are invited to participate in a research study in the Department of Audiology and 
Speech Pathology at the University of Tennessee, Knoxville. Your help will be greatly 
appreciated. If you are interested in participating in this study, please contact your 
speech-language pathologist. 
Researchers: Debra Suiter, MA, CCC-SLP and Gary McCullough, Ph.D., 
CCC-SLP 
Participants Needed: 18 adults with suspected difficulty swallowing, have a 
tracheostomy tube in place, and are non ventilator-dependent. 
Individuals with a history of previous neurological damage or 
swallowing problems will not be included in this study. 
Number of Sessions: You will be seen for one testing session only. 
Risks of the Project: You will be at risk for potential aspiration (water falling into 
your airway) during your swallow study. Aspiration is a known 
cause of pneumonia. Precautions will be taken during testing to 
minimize the likelihood of aspiration. You will also be exposed 
to a minimal amount of radiation during the x-ray study of your 
swallowing. This amount of radiation is similar to what you 
would normally experience in 2 months of natural background 
radiation. 
Benefit of the Project: This study will provide information regarding a means of 
reducing aspiration in patients with tracheostomy tubes. 
Confidentiality: 
Participation: 
The information in this study will be kept confidential. Data 
will be stored securely and will be made available only to those 
directly participating in the project unless permission is 
provided. 
Your participation is voluntary, and you may decline to 
participate at any time during the course of this study. If you 
withdraw, your data will be returned to you or destroyed. 
H you have any questions at any time about the study or the procedures, you may 
contact Debra Suiter at the UT Hearing and Speech Center, 974-8663. Hyou have 
questions regarding your rights as a participant, contact the Compliance Section of 
the Office of Research at 97 4-3466. 
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An Examination of the Effects of Passy-Muir Tracheostomy Speaking Valve 
Placement on Incidence and Severity of Aspiration in Tracheostomized Patients 
INFORMED CONSENT FOR PATIENTS 
You have been invited to participate in a research study. The purpose of this study is 
to investigate the effects of two conditions, cuff deflation and Passy-Muir Tracheostomy 
Speaking valve placement, on swallowing in patients with tracheostomy tubes. Your 
tracheostomy tube has a balloon-like cuff that can be filled with air. Some physicians 
believe that keeping air in the cuff (keeping it inflated) helps to prevent material such as 
food or liquid from falling into a patient's airways. However, having an inflated cuff 
may actually make it more difficult for you to swallow safely. We want to watch you 
swallow with the cuff inflated and with it deflated to see which way you swallow more 
safely. We also want to watch you swallow with a valve over your tracheostomy tube. 
It's called a Passy-Muir Tracheostomy Speaking Valve, and it allows a person to breathe 
in through your tracheostomy tube, but it closes when you breathe out so you can speak. 
In this study you will complete an x-ray swallowing study under three conditions: cuff 
inflated, cuff deflated, and cuff deflated with the Passy-Muir valve in place. You will be 
given two swallows of liquid mixed with barium and two swallows of applesauce mixed 
with barium to swallow under each condition (total of 12 swallows). 
Although every effort will be made to ensure your safety while participating in this 
study, you will be at risk for potential aspiration of material into your lungs. Aspiration 
is a known cause of pneumonia. However, we will have you swallow barium, which is 
known to be less likely to cause an infection than other food or liquid. We will take 
every precaution to minimize risks to you during the swallow study. Your physician has, 
and will continue to make, decisions about the management of your tracheostomy tube 
and your ability to take food by mouth. If you choose to participate in this study, your 
primary physician will be contacted and asked to share any concerns he has about the 
risks or benefits of your participation in this study. You will be exposed to a minimal 
amount of radiation during the x-ray swallowing study. This amount of radiation is 
similar to what one would normally receive in a I year period from our environment. 
By signing this consent form, you are not waiving any legal rights or releasing the 
University of Tennessee from liability or negligence. In the event of physical injury or 
illness resulting from the research procedures, the University of Tennessee does not have 
funds budgeted for compensation either for lost wages or for medical treatment. 
Therefore, the University does not provide for reimbursements for such injuries. 
You will not be paid for your participation in this study. However, the swallowing 
study is one which you would complete regardless of your participation in this study. 
Only the order of liquid and food presentation and the number of swallows you will 
complete will be changed. 
The information in the study records will be kept confidential. Data will be stored in 
Subject's Initials ____ _ 
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An Examination of the Effects Passy-Muir Tracheostomy Speaking Valve 
Placement on Incidence and Severity of Aspiration in Tracheostomized Patients 
INFORMED CONSENT FOR PATIENTS 
the office of the investigator at the University of Tennessee. No reference will be made 
in oral or written reports which could link you to the study. You will be asked to give 
permission for the use of videotapes for educational and professional purposes. 
However, you do not need to give permission in order to participate in this study. 
If you have questions at any time about the study or procedures, you may contact 
Debra Suiter at the University of Tennessee at (865)974-8663. 
Your participation in this study is voluntary. You may decline to participate without 
penalty. If you decide to withdraw from the study before data collection is completed, 
your data will be returned to you or destroyed. 
I have read the description of this study and I have freely volunteered to participate in it. 
I have had possible risks explained to me. I have had an opportunity to ask questions of 
the principle investigator and have received acceptable answers. I understand that I may 
withdraw from this study at any time without penalty. As the swallowing study is one 
which my doctor has already ordered and my completing the swallowing examination is 
not dependent on whether or not I participate in this research study, I understand that I 
will be responsible for the cost of the swallowing study. 
Participant's Signature __________________ Date __ _ 
Witness' Signature __________________ _ Date ---
Investigator's Signature _________________ Date __ _ 
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An Examination of the Effects of Passy-Muir Tracheostomy Speaking Valve 
Placement on Incidence and Severity of Aspiration in Tracheostomized Patients 
INFORMED CONSENT FOR PATIENTS 
You have been invited to participate in a research study. The purpose of this study is 
to investigate the effects of two conditions, cuff deflation and Passy-Muir Tracheostomy 
Speaking valve placement, on swallowing in patients with tracheostomy tubes. Your 
tracheostomy tube has a balloon-like cuff that can be filled with air. Some physicians 
believe that keeping air in the cuff (keeping it inflated) helps to prevent material such as 
food or liquid from falling into a patient's airways. However, having an inflated cuff 
may actually make it more difficult for you to swallow safely. We want to watch you 
swallow with the cuff inflated and with it deflated to see which way you swallow more 
safely. We also want to watch you swallow with a valve over your tracheostomy tube. 
It's called a Passy-Muir Tracheostomy Speaking Valve, and it allows a person to breathe 
in through your tracheostomy tube, but it closes when you breathe out so you can speak. 
In this study you will complete an x-ray swallowing study under three conditions: cuff 
inflated, cuff deflated, and cuff deflated with the Passy-Muir valve in place. You will be 
given two swallows of liquid mixed with barium and two swallows of applesauce mixed 
with barium to swallow under each condition (total of 12 swallows). 
Although every effort will be made to ensure your safety while participating in this 
study, you will be at risk for potential aspiration of material into your lungs. Aspiration 
is a known cause of pneumonia. However, we will have you swallow barium, which is 
known to be less likely to cause an infection than other food or liquid. We will take 
every precaution to minimize risks to you during the swallow study. Your physician has, 
and will continue to make, decisions about the management of your tracheostomy tube 
and your ability to take food by mouth. If you choose to participate in this study, your 
primary physician will be contacted and asked to share any concerns he has about the 
risks or benefits of your participation in this study. You will be exposed to a minimal 
amount of radiation during the x-ray swallowing study. This amount of radiation is 
similar to what one would normally receive in a I year period from our environment. 
By signing this consent form, you are not waiving any legal rights or releasing the 
University of Tennessee or the University of Tennessee Medical Center from liability or 
negligence. In the event of physical injury or illness resulting from the research 
procedures, the University of Tennessee does not have funds budgeted for compensation 
either for lost wages or for medical treatment. Therefore, the University does not provide 
for reimbursements for such injuries. 
You will not be paid for your participation in this study. However, the swallowing 
study is one which you would complete regardless of your participation in this study. 
Only the order of liquid and food presentation and the number of swallows you will 
complete will be changed. 
The information in the study records will be kept confidential. Data will be stored in 
Subject's Initials ____ _ 
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An Examination of the Effects of Passy-Muir Tracheostomy Speaking Valve 
Placement on Incidence and Severity of Aspiration in Tracheostomized Patients 
INFORMED CONSENT FOR PATIENTS 
the office of the investigator at the University of Tennessee. No reference will be made 
in oral or written reports which could link you to the study. You will be asked to give 
permission for the use of videotapes for educational and professional purposes. 
However, you do not need to give permission in order to participate in this study. 
If you have questions at any time about the study or procedures, you may contact 
Debra Suiter at the University of Tennessee at (865)974-8663. If during the course of 
this study you have questions concerning the nature of the research or your rights as a 
subject, please contact the office of the Institutional Review Board at (865)544-9781. 
Your participation in this study is voluntary. You may decline to participate without 
penalty. If you decide to withdraw from the study before data collection is completed, 
your data will be returned to you or destroyed. 
I have read the description of this study and I have freely volunteered to participate in it. 
I have had possible risks explained to me. I have had an opportunity to ask questions of 
the principle investigator and have received acceptable answers. I understand that I may 
withdraw from this study at any time without penalty. As the swallowing study is one 
which my doctor has already ordered and my completing the swallowing examination is 
not dependent on whether or not I participate in this research study, I understand that I 
will be responsible for the cost of the swallowing study. 
Participant's Signature __________________ Date __ _ 
Witness' Signature __________________ _ Date ---
Investigator's Signature _________________ Date __ _ 
Subject's Initials _____ _ 
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Placement on Incidence and Severity of Aspiration in Tracheostomized Patients 
INFORMED CONSENT FOR PATIENTS 
You have been invited to participate in a research study. The purpose of this study is 
to investigate the effects of two conditions, cuff deflation and Passy-Muir Tracheostomy 
Speaking valve placement, on swallowing in patients with tracheostomy tubes. Your 
tracheostomy tube has a balloon-like cuff that can be filled with air. Some physicians 
believe that keeping air in the cuff (keeping it inflated) helps to prevent material such as 
food or liquid from falling into a patient's airways. However, having an inflated cuff 
may actually make it more difficult for you to swallow safely. We want to watch you 
swallow with the cuff inflated and with it deflated to see which way you swallow more 
safely. We also want to watch you swallow with a valve over your tracheostomy tube. 
It's called a Passy-Muir Tracheostomy Speaking Valve, and it allows a person to breathe 
in through your tracheostomy tube, but it closes when you breathe out so you can speak. 
In this study you will complete an x-ray swallowing study under three conditions: cuff 
inflated, cuff deflated, and cuff deflated with the Passy-Muir valve in place. You will be 
given four swallows of liquid mixed with barium to swallow under each condition (total 
of 12 swallows). 
Although every effort will be made to ensure your safety while participating in this 
study, you will be at risk for potential aspiration, or inhalation of material into your lungs. 
Aspiration is a known cause of pneumonia. However, we will have you swallow barium, 
which is known to be less likely to cause an infection than other food or liquid. We will 
take every precaution to minimize risks to you during the swallow study. Your physician 
has, and will continue to make, decisions about the management of your tracheostomy 
tube and your ability to take food by mouth. If you choose to participate in this study, 
your primary physician will be contacted and asked to share any concerns he has about 
the risks or benefits of your participation in this study. You will be exposed to a minimal 
amount of radiation during the x-ray swallowing study. This amount of radiation is 
similar to what one would normally receive in a 1 year period from our environment. 
By signing this consent form, you are not waiving any legal rights or releasing the 
University of Tennessee or Ft. Sanders Regional Medical Center from liability or 
negligence. In the event of physical injury or illness resulting from the research 
procedures, the University of Tennessee and Ft. Sanders do not have funds budgeted for 
compensation either for lost wages or for medical treatment. Therefore, the University 
and Ft. Sanders do not provide for reimbursements for such injuries. 
You will not be paid for your participation in this study. However, the swallowing 
study is one which you would complete regardless of your participation in this study. 
Only the order of liquid and food presentation and the number of swallows you will 
complete will be changed. 
The information in the study records will be kept confidential. Data will be stored in 
Subject's Initials ____ _ 
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Placement on Incidence and Severity of Aspiration in Tracheostomized Patients 
INFORMED CONSENT FOR PATIENTS 
the office of the investigator at the University of Tennessee. No reference will be made 
in oral or written reports which could link you to the study. You will be asked to give 
permission for the use of videotapes for educational and professional purposes. 
However, you do not need to give pennission in order to participate in this study. 
If you have questions at any time about the study or procedures, you may contact 
Debra Suiter at the University of Tennessee Department of Audiology and Speech 
Pathology at (865) 974-8663 between the hours of8:00 a.m. and 5:00 p.m. Monday 
through Friday. If during the course of this study you have questions concerning the 
nature of the research or your rights as a subject, please contact the office of the 
Covenant Health System Institutional Review Board at (865) 541-1814. 
Your participation in this study is voluntary. You may decline to participate without 
penalty. If you decide to withdraw from the study before data collection is completed, 
your data will be returned to you or destroyed. 
I have read the description of this study and I have freely volunteered to participate in it. 
I have had possible risks explained to me. I have had an opportunity to ask questions of 
the principle investigator and have received acceptable answers. I understand that I may 
withdraw from this study at any time without penalty. As the swallowing study is one 
which my doctor has already ordered and my completing the swallowing examination is 
not dependent on whether or not I participate in this research study, I understand that I 
will be responsible for the cost of the swallowing study. 
Participant's Signature __________________ Date __ _ 
Witness' Signature __________________ _ Date ---
Investigator's Signature _________________ Date __ _ 
Subject's Initials ______ _ 
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Patient Infonnation/Consent Fonn 
An Examination of the Effects of Cuff Deflation and Passy-Muir Tracheostomy Speaking 
Valve Placement on Incidence and Severity of Aspiration in Tracheostomized Patients 
To be conducted at 
Baptist Hospital of East Tennessee 
137 Blount Avenue 
Knoxville, TN 37920 
PRINCIPAL INVESTIGATOR: Debra M. Suiter, MA, CCC-SLP, Doctoral Student in 
Speech Science 
SUBINVESTIGATOR: Gary H. McCullough, Ph.D., CCC-SLP 
You have been invited to participate in a research study. The purpose of this study is to 
investigate the effects of two conditions, cuff deflation and Passy-Muir Tracheostomy 
Speaking Valve placements, on swallowing in patients with tracheostomy tubes. Your 
tracheostomy tube has a balloon-like cuff that can be filled with air. Some physicians 
believe that keeping air in the cuff (keeping it inflated) helps prevent material such as 
food or liquid from falling into a patient's airways. However, having an inflated cuff 
may actually make it more difficult for you to swallow safely. We want to watch you 
swallow with the cuff inflated and with it deflated to see which way you swallow more 
safely. We also want to watch you swallow with a valve over your tracheostomy tube. 
It's called a Passy-Muir Tracheostomy Speaking Valve, and it allows a person to breathe 
in through your tracheostomy tube, but it closes when you breathe out so you can speak. 
In this study you will complete an x-ray swallowing study under three conditions: cuff 
inflated, cuff deflated, and cuff deflated with the Passy-Muir valve in place. You will be 
given four swallows of liquid mixed with barium to swallow under each condition (total 
of 12 swallows). 
Although every effort will be made to ensure your safely while participating in this study, 
you will be at risk for potential aspiration of material into your lungs. Aspiration is a 
known cause of pneumonia. However, we will have you swallow barium, which is 
known to be less likely to cause an infection than other food or liquid. We will take 
every precaution to minimize risks to you during the swallow study. Your physician has 
made, and will continue to make, decisions about the management of your tracheostomy 
tube and your ability to take food by mouth. If you choose to participate in this study, 
your primary physician will be contacted and asked to share any concerns he has about 
the risks or benefits of your participation in this study. You will be exposed to a minimal 
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One would normally receive in a one year period from our environment. You will not 
benefit directly from participating in this study. However, this study will help other 
patients and clinicians by providing information regarding swallowing function in 
tracheostomized patients. 
Your participation in this study is voluntary. No compensation for participation will be 
given. 
You are free to withdraw your consent to participate in this research study at any time 
without prejudice to your subsequent care. Refusing to participate will involve no 
penalty or loss of benefits. You are free to seek care from a physician of your choice at 
any time. If you do not take part or withdraw from the study, you will continue to receive 
care. 
If you know or suspect that you are pregnant, it is your obligation to inform the 
investigators. Individuals who are or may be pregnant should not participate in this 
study, as the radiation received during the x-ray swallowing study may be harmful to the 
fetus. 
Any information learned from this study will be kept confidential and disclosed only with 
your permission. Your records will be made available to Baptist Hospital of East 
Tennessee and the study sponsor. If information learned from this study is published in a 
journal, you will not be identified by name. 
No compensation is available for participating in this study. Also, no compensation is 
available for a physical or psychological injury which might occur as a result of this 
study. While medical care will be available should an injury occur, you will be billed for 
the costs of providing this care. 
If you have any questions about your rights as a participant in this study, about the study 
itself or if you have any problems or complaints or study related injuries you may call 
Mr. Jon Foster, Administrator, at (865) 632-5210. 
Initiated: 
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I agree to participate in the study described above. This consent is given based on the 
verbal and written information provided to me. My physician has told me that I am 
medically and physically qualified to participate in this study. I am free to ask questions 
at any time. I may seek information from any resource which might help my 
understanding of this study. 
The clinician responsible for the study at this institution (Principal Investigator: Debra 
Suiter, MA, CCC-SLP) may take me off the study if required to guarantee that my best 
interests will be served. If I encounter medical problems or complications, or have any 
questions about the study, I have been given the telephone number of my physician, {865) 
The purpose of this study is to investigate the effects of the Passy-Muir Tracheostomy 
Speaking valve on swallowing in tracheostomized patients. 
By consenting to participate in this study, I realize am responsible for carrying out 
instructions and that I must relate to my doctors, nurses, and other study personnel any 
information that might be pertinent to the study, such as side effects of a treatment or 
procedure. Any new information regarding this study and any treatment it involves 
which might affect my willingness to continue my participation in the study will be 
related to me in an appropriate way. 
I will receive a signed copy of this informed consent. 
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